SCHEMBL3281297

SCHEMBL3281297

CCCCCc1ncoc1CCCCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TLR7 Q9NYK1 2/20 0.36
KCNH2 Q12809 1/20 0.35
CYP3A4 P08684 3/20 0.34
CYP2D6 P10635 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGS2 P35354 4/20 0.32
DHFR P00374 1/20 0.32
CA2 P00918 1/20 0.32
ESR1 P03372 2/20 0.31
ADRA2A P08913 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
TACR2 P21452 2/20 0.31
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835691 0.83 CDC25A (0.45) TDP1MEN1KMT2AESR1ALDH1A1
SCHEMBL13361150 0.78 KCNH2 (0.38) TLR7KCNH2CYP3A4MEN1KMT2A
SCHEMBL12881245 0.77 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL25653978 0.76 TLR7 (0.43) TLR7KCNH2MEN1KMT2ADHFR
SCHEMBL18599000 0.74 IMPDH2 (0.36) KCNH2MEN1KMT2AALDH1A1
SCHEMBL4782648 0.72 HCAR2 (0.41) TDP1L3MBTL1CYP3A4MEN1KMT2A
SCHEMBL12866757 0.71
SCHEMBL1074604 0.70 TDP1 (0.47) TDP1L3MBTL1TLR7KCNH2CYP3A4
SCHEMBL532911 0.69 MEN1 (0.36) TDP1L3MBTL1TLR7KCNH2MEN1
SCHEMBL27818098 0.69 TDP1 (0.45) TDP1L3MBTL1TLR7KCNH2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114014849-A 4, 5-diaryl oxazole compound and application thereof 福建医科大学 2022-02-08 CN claimed
CN-113651806-A Preparation method of 4, 5-diaryl oxazole compound 福建医科大学 2021-11-16 CN claimed
JP-5139030-A None JP disclosed
EP-3102207-B1 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS AGENCY SCIENCE TECH & RES (SG) 2022-05-11 EP disclosed
CN-114014849-A 4, 5-diaryl oxazole compound and application thereof 福建医科大学 2022-02-08 CN disclosed
CN-114014849-A 4, 5-diaryl oxazole compound and application thereof 福建医科大学 2022-02-08 CN disclosed
CN-114014849-A 4, 5-diaryl oxazole compound and application thereof 福建医科大学 2022-02-08 CN disclosed
CN-113651806-A Preparation method of 4, 5-diaryl oxazole compound 福建医科大学 2021-11-16 CN disclosed
CN-113651806-A Preparation method of 4, 5-diaryl oxazole compound 福建医科大学 2021-11-16 CN disclosed
CN-113651806-A Preparation method of 4, 5-diaryl oxazole compound 福建医科大学 2021-11-16 CN disclosed
US-20210188838-A1 ANTI-BIOFILM COMPOUNDS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2021-06-24 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1999024397-A1 BENZOCYCLOHEPTENE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-05-20 WO disclosed
WO-1999021843-A1 4, 5-DIARYLOXAZOLE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-05-06 WO disclosed
CN-1196726-A 4,5-diaryl oxazole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1998-10-21 CN disclosed
EP-0736018-A1 4,5-DIARYLOXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-09 EP disclosed
WO-1995017393-A1 4,5-DIARYLOXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-06-29 WO disclosed
JP-H05139030-A THERMAL RECORDING MATERIAL MITSUI TOATSU CHEM INC 1993-06-08 JP disclosed
US-4225666-A Silver halide precipitation and methine dye spectral sensitization process and products thereof EASTMAN KODAK COMPANY (US) 1980-09-30 US disclosed
US-4183756-A PRECIPITATION OF WILVER HALIDE PARTICLES IN PRESENCE OF METHINE DYE EASTMAN KODAK COMPANY (US) 1980-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188838-A1 ANTI-BIOFILM COMPOUNDS FGB, SELP, SPPL2B TDP1 2073/4885L3MBTL1 2716/4885TLR7 3260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.